Sienna Biopharmaceuticals, Inc.
SNNAQ · OTC
12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $49 | $74 | $9 | $5 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $3 | $1 | $1 |
| Total Curr. Assets | $50 | $77 | $11 | $6 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $11 | $11 | $10 | $0 |
| Intangibles | $46 | $48 | $42 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $57 | $60 | $52 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $107 | $137 | $62 | $6 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $2 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $22 | $6 | $8 | $0 |
| Total Curr. Liab. | $24 | $8 | $10 | $1 |
| LT Debt | $30 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $11 | $11 | $9 | $0 |
| Other NC Liab. | $16 | $26 | $21 | $1 |
| Total NC Liab. | $56 | $37 | $30 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $81 | $46 | $40 | $2 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $60 | $20 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $159 | $86 | -$35 | -$14 |
| AOCI | $3 | $5 | -$0 | $0 |
| Other Equity | $183 | $172 | -$2 | -$2 |
| Total Equity | $159 | $86 | $22 | $4 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $240 | $132 | $62 | $6 |
| Net Debt | -$18 | -$74 | -$9 | -$5 |